Disease Markers / 2020 / Article / Tab 1 / Research Article
[Retracted] Assessing the Prognostic Performance of the Child-Pugh, Model for End-Stage Liver Disease, and Albumin-Bilirubin Scores in Patients with Decompensated Cirrhosis: A Large Asian Cohort from Gastroenterology Department Table 1 Characteristics of patients in the DeCi cohort.
Variable Patients with decompensated cirrhosis ( ) Sex (male), (%) 344 (75.4%) Age, median (IQR) 53.5 (46-63.75) Hospitalization days, median (IQR) 11 (9-13) Intensive care unit (%) 64 (14.0%) Cause of liver cirrhosis, (%) Viral 276 (60.5%) Alcoholic 72 (15.8) Combined alcoholic viral 37 (8.1%) Other 28 (6.1%) Cryptogenic 43 (9.4%) Cause of hospitalization, (%) Ascites 3 (0.7%) Gastrointestinal hemorrhage 407 (89.2%) Hepatic encephalopathy 22 (4.8%) Infection 24 (5.3%) Ascites degree, (%) No ascites 195 (42.8%) 1st-degree ascites 123 (27.0%) 2nd-degree ascites 80 (17.5%) 3rd-degree ascites 58 (12.7%) Renal failure, (%) 20 (4.4%) Hepatocellular carcinoma, (%) 56 (12.3%) Acute decompensation, (%) 436 (95.5%) Therapy, (%) Vasopressor support 144 (31.6%) Mechanical ventilation 27 (5.9%) Renal replacement therapy 2 (4.4%) 28-day outcome, (%) Lost to follow-up 31 (6.8%) Survivors 375 (82.2%) Nonsurvivors 50 (11.0%) 90-day outcome, (%) Lost to follow-up 77 (16.9%) Survivors 300 (65.8%) Nonsurvivors 76 (16.6%) 6-month outcome, (%) Lost to follow-up 132 (28.9%) Survivors 233 (51.1%) Nonsurvivors 91 (19.9%)
IQR: interquartile range.